Contact
searchSearch
HMP Global

Infectious Diseases Topic Center

Featured Article

Quiz
Insights into the Respiratory Syncytial Virus (RSV) Surge
03/21/2024
03/21/2024
Pharmacy Learning Network
Quiz
Age of RSV Infection Onset in Children
09/22/2023
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all...
09/22/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Finding Novel Therapies for COVID-19
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Losing Options for COVID-19: Monoclonal Antibodies vs Omicron Subvariants
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
Interview
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
How to Talk to Patients About the COVID-19 Vaccines
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
News
Countless Homebound Patients Still Wait for COVID-19 Vaccine Despite Priority of Older Adults
02/25/2021
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun...
02/25/2021
Pharmacy Learning Network
Improving Vaccine Delivery, Operations
Interview
Improving Vaccine Delivery, Operations
02/24/2021
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder,...
02/24/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
Reviewing New COVID Vaccine Data and the Effect on Accessibility
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
Ad Council Aims to Help Providers Better Understand Questions Expected About COVID-19 Vaccinations
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network

Newsfeed

News
How Effective Is the Influenza Vaccine Among Patients With COPD?
01/13/2020
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated...
01/13/2020
Pharmacy Learning Network
News
Factors Contributing to Influenza Vaccine Hesitancy Identified
11/25/2019
Amanda Balbi
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to...
11/25/2019
Pharmacy Learning Network
News
Statins Are Underprescribed, Prescribed at Lower Intensities in Patients With HIV
10/28/2019
Amanda Balbi
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
ATS Releases Guidelines On Diagnosing Fungal Infections
09/11/2019
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society...
09/11/2019
Pharmacy Learning Network
News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network
News
Class II Recall Issued for Chlorpromazine Tablets Due to Nitrosamine Impurity
04/10/2025
Danielle Sposato
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc.,...
04/10/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for QuVa Pharma Compounded Epidural Drug Products Due to Sterility Concerns
04/03/2025
Juliet Gallagher
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has...
04/03/2025
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Finding Novel Therapies for COVID-19
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Losing Options for COVID-19: Monoclonal Antibodies vs Omicron Subvariants
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
Interview
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
How to Talk to Patients About the COVID-19 Vaccines
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
Reviewing New COVID Vaccine Data and the Effect on Accessibility
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
Ad Council Aims to Help Providers Better Understand Questions Expected About COVID-19 Vaccinations
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network
Commentary
A Message of Hope During These Challenging Times
07/20/2020
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through...
07/20/2020
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use